“SBRT is commonly used as a treatment for early stage non-small cell lung cancer, and our results show strong tumor control. This suggests that SBRT may also be effective for lung neuroendocrine tumors,” said Oliver, assistant member of the Department of Radiation Oncology at Moffitt.” They performed a retrospective analysis of 48 lung neuroendocrine tumors… Read More »